We tested 53 clinical isolates of Branhamella catarrhalis recovered from patients with respiratory symptoms to determine the susceptibility of the isolates to 25 antimicrobial agents, including the newer β-lactam antibiotics. Of the 53 strains, 46 (86.7%) were β-lactamase producers. All the strains were susceptible to the majority of the new penicillins and cephalosporins. The combinations of amoxacillin-clavulanic acid and ticarcillin-clavulanic acid were also very active against the β-lactamase-producing strains.
|Original language||English (US)|
|Number of pages||2|
|Journal||Antimicrobial Agents and Chemotherapy|
|State||Published - 1985|
ASJC Scopus subject areas
- Pharmacology (medical)